Protara Therapeutics (TARA) Income from Continuing Operations: 2013-2014
Historic Income from Continuing Operations for Protara Therapeutics (TARA) over the last 2 years, with Dec 2014 value amounting to -$9.3 million.
- Protara Therapeutics' Income from Continuing Operations was N/A to -$3.3 million in Q4 2014 from the same period last year, while for Dec 2014 it was -$8.4 million, marking a year-over-year change of. This contributed to the annual value of -$9.3 million for FY2014, which is 16.48% down from last year.
- Protara Therapeutics' Income from Continuing Operations amounted to -$9.3 million in FY2014, which was down 16.48% from -$8.0 million recorded in FY2013.
- Protara Therapeutics' 5-year Income from Continuing Operations high stood at -$8.0 million for FY2013, and its period low was -$9.3 million during FY2014.
- For the 2-year period, Protara Therapeutics' Income from Continuing Operations averaged around -$8.6 million, with its median value being -$8.6 million (2013).
- Data for Protara Therapeutics' Income from Continuing Operations shows a maximum YoY declined of 16.48% (in 2014) over the last 5 years.
- Over the past 2 years, Protara Therapeutics' Income from Continuing Operations (Yearly) stood at -$8.0 million in 2013, then decreased by 16.48% to -$9.3 million in 2014.